Heloisa M. Resende
Volta Redonda, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.
Journal: Clinical breast cancer
Published: February 26, 2026
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.
Journal: JCO global oncology
Published: October 08, 2025
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: September 02, 2025
Optimizing breast cancer therapy: chemoressitance and machine learning for precision prediction.
Journal: Personalized medicine
Published: July 16, 2025
Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil.
Journal: Current oncology (Toronto, Ont.)
Published: July 01, 2025
Non-metastatic breast cancer in older patients in Brazil: Adherence to endocrine therapy, quality of life, and sexual health.
Journal: Journal of geriatric oncology
Published: May 25, 2025
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort.
Journal: Cancer treatment and research communications
Published: May 05, 2025
Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor-Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study.
Journal: JCO global oncology
Published: April 18, 2025
Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors.
Journal: Scientific reports
Published: April 11, 2025
Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
Journal: Clinical breast cancer
Published: March 19, 2025
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country.
Journal: JCO global oncology
Published: March 07, 2025
Last Updated: 09/26/2026